Nuclear Medicine: Page 361

PET perfusion can predict cardiac events
ATLANTA - Stress perfusion defects found with PET/CT are good predictors of coronary artery disease, while only overall perfusion defect changes are good predictors of cardiovascular events with PET, according to two studies presented at the American College of Cardiology (ACC) meeting.
March 14, 2006
IPL issues licenses
By AuntMinnie.com staff writers
As part of a court settlement, Isotope Products Laboratories (IPL) has granted licenses to International Isotopes and RadQual to reproduce radioactive sources for nuclear medical imaging.
March 13, 2006
PET, SPECT measures of LVEF have superior predictive value
ATLANTA - PET and SPECT measurements of left ventricular ejection fraction (LVEF) appear to be a better predictor of mortality than other measures in stress myocardial perfusion imaging (MPI), according to two studies presented at the American College of Cardiology (ACC) meeting.
March 12, 2006
Neoprobe renews Ethicon deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe said that interventional device firm Ethicon Endo-Surgery has renewed its marketing and distribution agreement with the company through December 2008.
March 12, 2006
F-18 fluoride PET/CT accurately detects bone metastases in high-risk prostate cancer
By Jonathan S. Batchelor
For high-risk prostate cancer patients, detecting osseous metastatic disease is critical in the management of their cancer. Recently, researchers from Israel studied planar bone scintigraphy, single and multiple field-of-view SPECT, PET, and PET/CT to see how they compared in detecting bone metastases in these patients.
March 9, 2006
Siemens, Cleveland Clinic ink SPECT tech deal
By AuntMinnie.com staff writers
Siemens Medical Solutions has signed a licensing agreement with the Cleveland Clinic in Ohio to market SPECT reconstruction and calibration software developed by researchers at the clinic, according to the Malvern, PA-based vendor.
March 8, 2006
NeoRx reports 'going-concern' warning
By AuntMinnie.com staff writers
Oncology pharmaceutical firm NeoRx said that its auditor KPMG has included a "going-concern" qualification in its audit opinion of the Seattle-based firm's 2005 financial statements.
March 8, 2006
PET/CT shows slight edge over MRI in melanoma staging
By Jonathan S. Batchelor
VIENNA - A recent prospective study comparing whole-body MRI with whole-body PET/CT in staging newly diagnosed malignant melanoma demonstrated that PET/CT has a slight edge in accuracy, but that both modalities missed local and distant metastases.
March 7, 2006
AuntMinnie.com Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
March 5, 2006
SNM disburses technologist, physician grants
By AuntMinnie.com staff writers
The Society of Nuclear Medicine (SNM) recently awarded $58,000 in scholarships and grants for molecular/nuclear medicine technologist students.
February 27, 2006
Siemens, PETNet buy New England PETNet
By AuntMinnie.com staff writers
Siemens Medical Solutions and subsidiary PETNet Pharmaceuticals have purchased full ownership of the New England PETNet manufacturing and distribution center in Woburn, MA.
February 26, 2006
Schering, IBA ink radiopharma deal
By AuntMinnie.com staff writers
German contrast media firm Schering said that its French subsidiary, Schering S.A.S., will transfer the radiopharmaceutical business of CIS bio international to a consortium formed by Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, and the Institut National des Radioéléments of Walloon, Belgium.
February 22, 2006
Previous Page
Page 361 of 439
Next Page